Biotech News
Related news
LUNGPulmonx2026-07-29 20:05 EST
Pulmonx Reports Second Quarter 2026 Financial Results
LUNGPulmonx2026-07-28 20:05 EST
Pulmonx to Present at the Canaccord Genuity 46th Annual Growth Conference
PAVMPAVmed2026-08-04 12:30 EST
Lucid Diagnostics to Participate in Upcoming Investor Conferences
AORTArtivion2026-07-28 20:10 EST
Artivion to Participate in Upcoming Investor Conferences
ANGOAngioDynamics2026-07-28 12:30 EST
AngioDynamics to Participate in Upcoming Investor Conferences
ATRCAtriCure2026-07-27 12:00 EST
AtriCure to Participate at Upcoming Investor Conferences
ADPTAdaptive Biotechnologies2026-05-21 20:18 EST
Adaptive Biotechnologies to Participate in Upcoming Investor Conferences
LMATLeMaitre Vascular2026-05-20 20:25 EST
LeMaitre to Participate at Upcoming Investor Conferences in June
IRTCiRhythm2026-05-19 20:05 EST
iRhythm Holdings to Participate in Upcoming Investor Conferences
MMSIMerit Medical2026-08-05 16:00 EST
Merit Medical to Participate in Upcoming Investors Conferences in August
Pulmonx
Minimally Invasive COPD Treatment Pulmonx develops minimally invasive technologies for patients with severe emphysema and chronic obstructive pulmonary disease who remain highly symptomatic despite medical therapy. Zephyr Endobronchial Valve The Zephyr Valve is an implantable bronchoscopic device that occludes selected diseased lung...
Recent company news
LUNGPulmonx2026-07-29 20:05 EST
Pulmonx Reports Second Quarter 2026 Financial Results
LUNGPulmonx2026-07-28 20:05 EST
Pulmonx to Present at the Canaccord Genuity 46th Annual Growth Conference
LUNGPulmonx2026-07-15 20:05 EST
Pulmonx to Report Second Quarter 2026 Financial Results on July 29, 2026
LUNGPulmonx2026-06-01 20:05 EST
Pulmonx Corporation Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
LUNGPulmonx2026-04-29 20:05 EST
Pulmonx Reports First Quarter 2026 Financial Results
Stock data
- Close
- 2.05 USD
- Market cap
- 68M USD
- Exchange
- NASDAQ
- Sector
- MedTech
- Location
- United States